Loading

Journal of Pharmacology and Clinical Toxicology

In silico Docking Studies of Some Isolated Compounds of Clausena Lansium (Lou.) Against Diabetic Activity

Research Article | Open Access | Volume 6 | Issue 1

  • 1. Department of Pharmacy, BGC Trust University Bangladesh, Bangladesh
  • 2. Department of Pharmacy, University of Chittagong, Bangladesh
  • 3. Department of Pharmacy, University of Science and Technology Chittagong, Bangladesh
  • 4. Department of Theoritical and Computational Chemistry, Dhaka University, Bangladesh
  • 5. Department of Pharmacy, East West University, Bangladesh
  • 6. Department of Microbiology, Jagannath University, Banglades
  • 7. GUSTO A Research Group, Banglades
+ Show More - Show Less
Corresponding Authors
Arkajyoti Paul, Department of Microbiology, Jagannath University, Bangladesh, Tel: 880176604078
Abstract

The aim of this study is to perform molecular docking studies to identify potential binding affinities of the phyto-compounds from compounds claulamines E, clausemarin B, Clausenaline C, Clausenaline E, Murrayanine, vanillic acid, Xanthotoxol for searching of lead molecule for anti-diabetic activity. 
Computer assisted drug design approach has contributed to successfully disclosure of against diabetic agent. Molecular docking keeps on being a great promise in the field of computer based drug design.
The procedure of molecular docking includes investigation of various holding methods of one ligand with targeted receptors protein. We have found that numerous values of Molecular docking score by Schrodinger. Compounds claulamines E, clausemarin B, Clausenaline C, Clausenaline E, Murrayanine, vanillic acid, Xanthotoxol respectively. Among all the compounds Clausenaline E showed the best docking score. So from this investigation we can say that this compound Clausenaline E can be suggested for further experiment for the grater pharmacological effect in diabetic patient.

Keywords

• Piper-sylvaticum

• Molecular docking

• Thrombolytic activity

Citation

Nihar SW, Hoque Tanim MA, Siddique TI, Hoque A, Sultana S, et al. (2018) In silico Docking Studies of Some Isolated Compounds of Clausena Lansium (Lou.) Against Diabetic Activity. J Pharmacol Clin Toxicol 6(1):1100.

INTRODUCTION

In South Asian countries diabetes has become the seventh leading attributable risk factor [1,2]. By 2035 the number of affected people is expected to increase to 592 million globally [3]. About 80% of adults suffer in diabetes in low- and middle-income countries [4]. Diabetes is a serious complex condition which can affect the entire body. Blood glucose is the main source of energy and comes from the food we eat. Diabetes is a disease that occurs when blood glucose is too high. Insulin, a hormone is prroduced by the pancreas which enables glucose from food to get into our cells to be used for energy. Therefore, there has been a developing interest to analyze the antidiabetic properties of plants. A large number of plants and plant-parts have been investigated for their beneficial role and anti-diabetic properties [5,6].

Clausena lansium (Lou.) has a place with the family Rutaceae and is started from Southern China and discovered likewise in Bangladesh, India and so forth. The mash can be utilized to plan organic product mugs, sweets, stick, or jam. What’s more, the matured natural product can be utilized to plan carbonated refreshments like champagne, albeit dried Clausena lansium is a more attractive product. Previous investigations of bioactivities, especially the concentrates of its leaf and seed, for the most part centered around the hepatoprotective, antiplatelet, hypoglycemic, antifungal and antiviral activities. In any case, no methodical investigation has been directed on the Clausena lansium peel despite the fact that it is utilized as a people medication in China for the treatment of stomachic, and bronchitis and additionally it goes about as a vermifuge. Out of the blue, this examination researched the cancer prevention agent and anticancer exercises of the Clausena lansium peel removes and showed the strong bioactivities of the concentrates appropriate to be utilized as characteristic cell reinforcement mixes or pharmaceutical supplements [7-11].

Molecular docking is a key apparatus in computer-assisted drug design and development. Docking has been used to perform virtual screening on extensive libraries of compounds and propose basic theories of how the ligands bind with the target with lead optimization. Another potential use of docking is optimization stages of the drug-discovery cycle.

MATERIALS AND METHODS

Protein preparation

3D crystal structure of Pancreatic Alpha-Amylase With A Carbohydrate Inhibitor is downloaded from Protein Data Bank [12]. By using the Protein Preparation Wizard of SchrödingerMaestro v 10.1 the structure was prepared and refined. Charges and bond orders were assigned, hydrogens are added to the heavy atoms, were converted to methionines, and all waters were deleted. By Using force field OPLS_2005 minimization was carried out setting maximum heavy atom RMSD to 0.30 Å.

Preparation of ligand

Compounds were retrieved from Pubchem databases, i.e claulamines E, clausemarin B, Clausenaline C, Clausenaline E, Murrayanine, vanillic acid, Xanthotoxol. The 2D structures for these were built by using Schrödinger-Maestro v 10.1.

Receptor grid generation

Receptor grids were calculated for prepared proteins such that various ligand poses bind within the predicted active site during docking.Grids were generated keeping the default parameters of van der Waals scaling factor 1.00 and charge cutoff 0.25 subjected to OPLS 2005 force field in glide. A cubic box of specific dimensions centred around the centroid of the active site residues (Reference ligand active site) was generated for receptor. For docking experiments, The bounding box was set to 14 × 14 × 14.

Glide standard precision (SP) ligand docking

SP flexible ligand docking was carried out in Glide of Schrödinger-Maestro v10.1 [13,14], within which penalties were applied to non-cis/trans amide bonds. Van der Waals scaling factor and partial charge cutoff was selected to be 0.80 and 0.15, respectively for ligand atoms. Final scoring was performed on energy-minimized poses and displayed as Glide score. The lowest Glide score value was recorded for each ligand as the best docked pose

RESULT

In order to study the interaction of the compounds claulamines E, clausemarin B, Clausenaline C, Clausenaline E, Murrayanine, vanillic acid, Xanthotoxol with 1PPI, we performed Glide docking analysis by Schrodinger suite v 10.1, where among of these compounds Clausenaline E shows highest docking score -5.467 shown in Table 1.

Table 1: Docking analysis of claulamines E, clausemarin B, Clausenaline C, Clausenaline E, Murrayanine, vanillic acid, Xanthotoxol with 1PPI.

Compounds Compound Code Docking Score Glide e model Glide energy
claulamines E 101879361 -5.276 -46.706 -33.319
clausemarin B 101879359 -4.86 -44.094 -34.267
Clausenaline C 101879360 -5.296 -46.246 -35.176
Clausenaline E 86106588 -5.467 -40.039 -28.389
Murrayanine 96942 -5.155 -34.288 -23.629
vanillic acid 8468 -4.634 -33.626 -27.639
Xanthotoxol 65090 -5.21 -37.863 -28.166

The negative and low value of Piperine glide energy of binding demonstrates a strongly favorable bond between 1PPI and in most favorable conformations. The results of docking analysis was described in Table 1 and Figure 1.

 Docking results of Piperine, Piperlonguminine, ?-sitosterol and N-isobutyl deca-trans-2-trans-4-dienamide with tissue plasminogen  activator (PDB: 1A5H).

Figure 1 Docking results of Piperine, Piperlonguminine, β-sitosterol and N-isobutyl deca-trans-2-trans-4-dienamide with tissue plasminogen activator (PDB: 1A5H).

DISCUSSION

Since there is no cure for diabetes yet there are approaches to bring down the dangers. Despite the fact that diabetes is confusion, it can likewise prompt different factors, for example, heart assault, kidney disappointment, or passing. A man with diabetes needs to keep up a sound way of life including eating the correct nourishment, working out, controlling their glucose level, and be hopeful [15-19].

Diabetes happens in a few structures however the real ones are Type I and I. Our computer aided drug-design has successfully discovered the source of several anti-diabetic agents. We tried to find out the maximum effect of compound which may give better therapeutic effect for diabetes with fewer side effects. From the above table we can determine the compound Clausenaline E shows the greatest binding affinity for the targeted receptor. And the docking score Clausenaline E glide emodel and glide energy shows that the particular compound Clausenaline E can give the better therapeutic effect than others.

CONCLUSION

From overall study we can estimate that the compound can be suggested for further in vivo experiments. If we go through all data and studies it shows how it clearly indicated that Clausenaline E can be utilized to care for diabetes. Our investigations may lay the base of further investigation of the - for its ant diabetic potential. The above discoveries additionally approve the ethno pharmacological information on this plant. Thus, it can be inferred that has high potential as ant diabetic particularly against pathway in diabetes.

ACKNOWLEDGEMENTS

The authors thank GUSTO A Research Group for providing the the financial support and software.

REFERENCES

1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013; 380: 2224-2260.

2. Rahman MS, Akter S, Abe SK, Islam MR, Mondal MN, Rahman JA, et al. Awareness, treatment, and control of diabetes in Bangladesh: a nationwide population-based study. PloS One. 2015; 10: e0118365.

3. Guariguata L,Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014; 103: 137-149.

4. Federation ID. IDF diabetes atlas. Brussels: International Diabetes Federation. 2013.

5. Yeo J, Kang YM, Cho SI, Jung MH. Effects of a multi-herbal extract on type 2 diabetes. Chin Med. 2011; 6: 10.

6. Kumar S, Saini M, Kumar V, Prakash O, Arya R, Rana M, et al. Traditional medicinal plants curing diabetes: A promise for today and tomorrow. Asian J Traditional Med. 2012; 7: 178-188.

7. Malmberg A, Yaksh T. Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science. 1992; 1276-1279.

8. Liu GT, Li WX, Chen YY, Wei HL. Hepatoprotective action of nine constituents isolated from the leaves of Clausena lansium in mice. Drug Dev Res. 1996; 39: 174-178.

9. Fan GJ, Han BH, Kang YH, Park MK. Evaluation of inhibitory potentials of chinese medicinal plants on platelet-activating factor (PAF) receptor binding. Natural Product Sciences. 2001; 7: 33-37.

10. Morton JF. Fruits of warm climates. 1987.

11. Shen Z. The hypoglycemic effect of clausenacoumarine. Yao xue xue bao= Acta pharmaceutica Sinica, 1989; 24: 391-392.

12. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat N, Weissig H, et al. The Protein Data Bank, 1999-, in International Tables for Crystallography Volume F: Crystallography of biological macromolecules. Springer. 2006; 675-684.

13. Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004; 47: 1739-1749.

14. Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, et al. Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein− ligand complexes. J Med Chem. 2006; 49: 6177-6196.

15. Anjana R, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, et al. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: Phase I results of the Indian Council of Medical Research–India Diabetes (ICMR–INDIAB) study. Diabetologia. 2011; 54: 3022-3027.

16. Kaushik P, Kokhra SL, Rana AC, Kaushik D. Pharmacophore modeling and molecular docking studies on Pinus roxburghii as a target for diabetes mellitus. Adv Bioinformatics. 2014.

17. Tota K, Rayabarapu N, Moosa S, Talla V, Bhyravbhatla B, Rao S. InDiaMed: a comprehensive database of Indian medicinal plants for diabetes. Bioinformation. 2013; 9: 378.

18. Marles RJ, Farnsworth NR. Antidiabetic plants and their active constituents. Phytomedicine. 1995; 2: 137-189.

19. Kaushik P, Kaushik D, Khokra SL. Ethnobotany and phytopharmacology of Pinus roxburghii Sargent: a plant review. J Integr Med. 2013; 11: 371-376.

Chakrabarty N, Suez E, Shil S, Rudra P, Rumpa FT, et al. (2018) In silico Molecular Docking of Some Isolated Compounds of Piper-Sylvaticum against Thrombolytic Activity. J Pharmacol Clin Toxicol 6(1):1101.

Received : 25 Jan 2018
Accepted : 31 Jan 2018
Published : 31 Jan 2018
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X